comparemela.com

Latest Breaking News On - Alphaganp ophthalmic solution - Page 1 : comparemela.com

Alembic Pharma shares up 5% on USFDA approval for glaucoma drug

Alembic Pharmaceuticals share touched a 52-week high of Rs 792.30 on April 28, 2022 and a 52-week low of Rs 463.30 on March 29

United statesDrug administrationAbbvie incAlembic pharmaceuticalsAlembic pharmaAlphaganp ophthalmic solutionAlembic pharmaceuticals share price

Alembic Pharmaceuticals announces USFDA Final Approval for Brimonidine Tartrate Ophthalmic Solution, 0 15%

Alembic Pharmaceuticals Limited today announced that it has received final approval from the US Food & Drug Administration for its Abbreviated New Drug Application Brimonidine Tartrate Ophthalmic Solution, 0.15%.

Alembic pharmaceuticalsAlembic pharmaceuticals limitedAbbvie incUs food drug administrationBrimonidine tartrate ophthalmic solutionPharmaceuticals limitedDrug administrationAbbreviated new drug applicationAlphaganp ophthalmic solutionTartrate ophthalmic solution

vimarsana © 2020. All Rights Reserved.